EOLS, Evolus, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for EOLS

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask EOLS by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(TXMD) TherapeuticsMD, Inc


Latest YouTube Video:



CEO:Mr. David Moatazedi

Headquarter: 520 Newport Center Drive, Suite 1200, Newport Beach, CA, United States, 92660

Industry: Drug Manufacturers - Specialty & Generic,   Investment Track: aesthetic medical products,   Employees: 334

Business Summary

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.